Skip to content

4Accepted Jun 16, 3:40 PM ET

Leonard Braden Michael 4

ANTXAN2 Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

3:40 PM

Jun 16, 2025

Filed

Jun 16, 2025

Documents

1

Size

5.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.